Paxbp1 restrains cytotoxic and innate cell programs in CD4+ T cells to promote Th2 differentiation
Danielle A. Chisolm(National Institutes of Health), John J. O’Shea(National Institute of Arthritis and Musculoskeletal and Skin Diseases)
Cited by 0
Related Papers
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
|The Journal of Immunology|2011|634
Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory Syndrome
|New England Journal of Medicine|2023|78
STAM2, a new member of the STAM family, binding to the Janus kinases
|FEBS Letters|2000|76